Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

James J. Driscoll^1*, Jason Burris^1,2 and Christina M. Annunziata¹

¹Medical Oncology Branch, National Cancer Institute, 10 Center Drive, Building 10-Room 12N-226, Magnuson Cancer Center, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America

²Hematology-Oncology Service, Department of Medicine, Walter Reed Army Medical Center, 6900 Georgia Ave NW, Washington, DC 20307, United States of America

^*Corresponding Author: James J. Driscoll, Medical Oncology Branch, National Cancer Institute, 10 Center Drive Building 10-Room 12N-226, United States of America, Tel: 301-451-4401, Fax: 301-480-6255 Email: